<DOC>
	<DOCNO>NCT01992146</DOCNO>
	<brief_summary>Recent study focus role endogenous opioids central sensitization . Central sensitization know impaired alter chronic pain condition , fibromyalgia chronic tension headache . Animal study show reinstatement mechanical hypersensitivity follow naloxone administration resolution injury . This suggest latent sensitization . In present study , investigator hypothesize high-dose target-controlled naloxone infusion ( total dose : 3.25 mg/kg ) reinstate pain hyperalgesia 6-8 week unilateral primary open groin hernia repair procedure . Investigators aim show latent sensitization present human modulate endogenous opioids .</brief_summary>
	<brief_title>Effect High-dose Naloxone Infusion Pain Hyperalgesia Patients Following Groin-Hernia Repair .</brief_title>
	<detailed_description />
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Hyperalgesia</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<criteria>Age ≥ 18 year ≤ 65 year Signed informed consent Patients submit unilateral , primary inguinal , open herniotomy 68 week prior study start . Open operate procedure a.m. Lichtenstein . Urin sample without trace opioids ( morphine , methadon , buprenorphine , codeine , tramadol , ketobemidone , oxycodone , hydromorphine , dextromethorphan ) ASA III Body mass index ( BMI ) : 18 &lt; BMI &lt; 30 Volunteers , speak understand Danish Patients , cooperate investigation Patients previous surgery groin region Patients pain rest &gt; 3 ( NRS ) Activityrelated pain surgical field &gt; 5 Allergic reaction morphine opioids ( include naloxone ) , Abuse alcohol drug accord investigator 's evaluation Use psychotropic drug ( exception SSRI ) Neurologic psychiatric disease Chronic pain condition Regular use analgesic drug Skin lesion tattoo assessment area Nerve lesion assessment site ( instance , trauma , disc herniation , etc . ) Use prescription drug 1 week trial Use overthecounter drug 48 hour trial</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>central sensitization</keyword>
	<keyword>endogenous opioids</keyword>
	<keyword>human</keyword>
	<keyword>latent sensitization</keyword>
	<keyword>naloxone</keyword>
	<keyword>open groin hernia repair</keyword>
	<keyword>pain</keyword>
	<keyword>randomize control trial</keyword>
	<keyword>secondary hyperalgesia</keyword>
	<keyword>target-controlled infusion</keyword>
</DOC>